The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| BO4 | N/A | N/A | N/A | N/A |
| S&P | +17.71% | +82.14% | +12.73% | N/A |
Borregaard ASA is a holding company, which engages in the development, production, and marketing of biochemicals. It operates through the following segments: BioSolutions; BioMaterials; and Fine Chemicals. The BioSolutions inlclude selling of biopolymers and biovanillin from lignin. The BioMaterials segment involves in the production of cellulose mainly for use as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products. The Fine Chemicals segment consists pharma intermediates and second-generation bioethanol. The company was founded in 1889 and is headquartered in Sarpsborg, Norway.
No news articles found for Borregaard Asa.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $152.47M | -8.0% |
| Gross Profit | $24.83M | -24.1% |
| Gross Margin | 16.29% | -3.5% |
| Market Cap | $1.65B | -1.5% |
| Market Cap / Employee | $1.38M | 0.0% |
| Employees | 1.2K | 0.0% |
| Net Income | $16.10M | -23.6% |
| EBITDA | $37.29M | -16.3% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $18.08M | 23.6% |
| Accounts Receivable | $91.24M | 0.0% |
| Inventory | 129.1 | 11.6% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $144.06M | -12.6% |
| Short Term Debt | $50.84M | 93.4% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 8.69% | -0.1% |
| Return On Invested Capital | 12.21% | 0.6% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $24.08M | 12.0% |
| Operating Free Cash Flow | $35.42M | 8.1% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 21.84 | 20.04 | 22.03 | 23.30 | -3.02% |
| Price to Book | 3.46 | 3.46 | 3.29 | 3.48 | -10.81% |
| Price to Sales | 2.36 | 2.28 | 2.51 | 2.54 | -2.82% |
| Price to Tangible Book Value | 3.51 | 3.52 | 3.34 | 3.53 | -10.91% |
| Price to Free Cash Flow TTM | 18164.58 | 60.02 | 301.02 | 207.02 | 96.94% |
| Enterprise Value to EBITDA | 51.39 | 38.53 | 41.78 | 49.11 | 17.35% |
| Free Cash Flow Yield | 0.0% | 1.7% | 0.3% | 0.5% | -49.22% |
| Return on Equity | 16.4% | 16.3% | 16.7% | 15.1% | -9.96% |
| Total Debt | $197.53M | $203.70M | $206.41M | $194.90M | 1.96% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
